| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | -10.0% |
| R&D Expense | $23.1M | +28.3% |
| SG&A Expense | $12.0M | +48.6% |
| Operating Income | -$34.1M | -36.6% |
| Net Income | -$33.0M | -33.3% |
| EPS (Basic) | -$1.37 | -14.2% |
| EPS (Diluted) | -$1.37 | -14.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $108.9M | +39.9% |
| Current Assets | $110.9M | +39.1% |
| Total Assets | $114.2M | +42.1% |
| Current Liabilities | $10.6M | +55.4% |
| Total Liabilities | $47.7M | +597.2% |
| Stockholders' Equity | $66.5M | -9.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.6M | +141.4% |
| Capital Expenditures | $366K | +175.2% |
| Investing Cash Flow | -$366K | -175.2% |
| Financing Cash Flow | $23.1M | -34.4% |
| Free Cash Flow | $8.3M | +139.4% |